TITLE:
Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation

CONDITION:
Smoking

INTERVENTION:
nortriptyline

SUMMARY:

      Treatment of smokers with a tricyclic antidepressant, nortriptyline, can reduce tobacco
      withdrawal symptoms and increases long term cessation rates when combined with transdermal
      nicotine and a behavioral cessation programs. The study is a placebo-controlled, randomized,
      parallel group trial in which smokers aged 18-70 will be subject to the combination of oral
      and patch treatments.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  Aged 18-70,

          -  smoking > 10 cigarettes per day,

          -  no current major depression,

          -  no concurrent psychiatric medications

        Exclusion Criteria:
      
